CSBR vs JPM · P/E 16, rev $56.9M vs P/E 14, rev $182.45B
Champions Oncology Inc (CSBR) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the CSBR and JPM stock pages for the full models.
Not investment advice.